Follow Mazen Noureddin, MD, MHSc
Follow Mazen Noureddin, MD, MHSc
Make a free account and we’ll email you when they’re booked to speak, or their slides or recordings are posted.
Get an email when they’re booked to speak.
Mazen Noureddin, MD, MHSc
Houston Methodist Hospital
5 talks · 1 event
Speaking
2026
-
Nov 5–9
The Liver Meeting 2026 Upcoming
-
Real-World, Data-Driven Strategies to Improve Outcomes in Cirrhosis and Metabolic Disease
-
Academic Debate: Is Resmetirom or Semaglutide the Best First-Line Treatment for Metabolic Dysfunction–Associated Steatohepatitis With Stage 2–3 Fibrosis?
Panelist
-
Pediatric Metabolic Dysfunction–Associated Steatotic Liver Disease Pharmacotherapy: Pathways to Regulatory Approval
-
Does One Size Fit All? Considerations for Incretin Use in Special Populations
-
Clinical Trial Pipeline for MASH 2026
-